These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
x
|
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
o
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
SYMBID CORP.
|
|
(Exact name of registrant as specified in its charter)
|
|
Nevada
|
45-2859440
|
|
|
(State or other jurisdiction of incorporation or organization)
|
(IRS Employer Identification No.)
|
|
Marconistraat 16, 3029 AK Rotterdam, The Netherlands
|
||
|
(Address of principal executive offices)
|
(Postal Code)
|
|
+31(0)108900400
|
|
(Registrant’s telephone number, including area code)
|
|
Large Accelerated Filer
o
|
Accelerated Filer
o
|
||
|
Non-Accelerated Filer
o
|
Smaller reporting company
x
|
||
|
(Do not check if a smaller reporting company)
|
|||
| CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS | 1 | ||
| PART I | 2 | ||
|
ITEM 1.
|
BUSINESS
|
2
|
|
|
ITEM 1B.
|
UNRESOLVED STAFF COMMENTS
|
39
|
|
|
ITEM 2.
|
PROPERTIES
|
39
|
|
|
ITEM 3.
|
LEGAL PROCEEDINGS
|
39
|
|
|
ITEM 4.
|
MINE SAFETY DISCLOSURES
|
39
|
|
| PART II | 40 | ||
|
ITEM 5.
|
MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES
|
40
|
|
|
ITEM 6.
|
SELECTED FINANCIAL DATA
|
45
|
|
|
ITEM 7.
|
MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
|
45
|
|
|
ITEM 7A.
|
QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
|
55
|
|
|
ITEM 8.
|
FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA
|
55
|
|
|
ITEM 9.
|
CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE
|
55
|
|
|
ITEM 9A.
|
CONTROLS AND PROCEDURES
|
55
|
|
|
ITEM 9B.
|
OTHER INFORMATION
|
57
|
|
| PART III | 58 | ||
|
ITEM 10.
|
DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE
|
58
|
|
|
ITEM 11.
|
EXECUTIVE COMPENSATION
|
62
|
|
|
ITEM 12.
|
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS
|
64
|
|
|
ITEM 13.
|
CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE
|
66
|
|
|
ITEM 14.
|
PRINCIPAL ACCOUNTANT FEES AND SERVICES
|
67
|
|
| PART IV | 68 | ||
|
ITEM 15.
|
EXHIBITS AND FINANCIAL STATEMENT SCHEDULES
|
68
|
|
|
SIGNATURES
|
72 | ||
|
●
|
Limited or no structured distribution channels for SME finance other than banks, increasing the mismatch between entrepreneurs and financiers;
|
|
●
|
No centralized platform for (alternative) financiers, making it difficult and inefficient to find the right financier at the right time;
|
|
●
|
No standardized data protocols for SME data, leading to costly and time-intensive (offline) screening and monitoring;
|
|
●
|
Limited financial skills of entrepreneurs leading to unnecessary inefficiencies and obstacles within the financing process; and
|
|
●
|
Decline in bank financing due to new regulations and recent financial crises, leaving a vacuum in the life cycle of SME financing.
|
|
Direct equity investor in private company
|
Investor as member of a cooperative
|
|
|
Voting rights regarding decisions within target company
|
Voting rights regarding decisions within cooperative and representative share of voting rights based on ownership percentage in the investment
|
|
|
Pay-out of dividends directly from the target company
|
Pay-out of dividends from the cooperative received from the target company
|
|
|
Ability to transfer securities to third parties, dependent on contractual agreements with the private companies
|
Significant restrictions on the transferability of memberships, which can only be made to members within the cooperative, subject to the approval of the cooperative’s Board of Directors. No ability to transfer securities to third parties
|
|
CREATE
: The entrepreneur and advisor together create a funding request in a standardized deal format.
SHARE
: The standardized funding request can be shared with a variety of institutional investors, and a network of over 36,000 private (crowdfunding) investors, who can invest from as little as € 20 ($22). Deals can be shared publically (open) or privately (closed).
MATCH
: We match deals with the right investors based on personalized preferences and can facilitate the settlement if required.
MONITOR
: Ongoing financial analysis of private companies, resulting in reporting for optimal risk and return management. Financial data can be imported into our monitoring from the accountant reporting system. Standardized data allows for comparing the performance of companies. Investors and entrepreneurs both use a personalized dashboard based on pre-set Key Performance Indication (“KPI”) relating to a particular company.
|
|
●
|
Equity based: crowdfunding for financial return through revenue and profit sharing; and
|
|
●
|
Lending based: crowdfunding for financial return through interest on a loan.
|
|
FAC B.V.
|
On July 29, 2014, we entered into a Share Purchase Agreement with our wholly owned subsidiary, Symbid Holding B.V., and FAC 2 B.V., a limited liability corporation incorporated in The Netherlands. Pursuant to the Share Purchase Agreement, we acquired FAC B.V. (“Acquiree”), a limited liability corporation incorporated in The Netherlands from FAC 2 B.V. in exchange for 2,750,000 shares of our restricted common stock. Acquiree owns a perpetual, worldwide, exclusive license to infrastructure technology upon which we intend to develop a platform to enable cloud based financing solutions for small and medium sized enterprises, expanding on our current equity based crowdfunding solutions in the Netherlands. The license provides the required technology for ongoing monitoring of private companies. Financial data can be imported into Symbid monitoring from the accountant reporting system resulting in powerful reporting for optimal risk and return management. Standardized data allows for comparing the performance of companies. Investors and entrepreneurs get a personal dashboard with KPI’s for key variables and covenants.
|
|
|
Equidam Holding B.V.
|
Equidam Holding B.V., founded in August 2013, is one of the first companies to be organized in any country as a crowdfunding service provider. Started as an online valuation tool for private companies with a particular focus on Small and Medium-sized Enterprises, Equidam Holding B.V. now also offers monitoring services to investors on the Symbid platform. In addition to Equidam Holding B.V.’s relationship with Symbid, this company has entered partnerships with European crowdfunding platforms to provide its services to these platforms as well. Symbid currently owns a 7% direct interest in Equidam Holding B.V. following an additional round of financing by Equidam Holding B.V. in which we determined not to participate.
|
|
|
Fortion Holding B.V.
|
Fortion Holding B.V. is providing under the brand name Credion financial advisory services in the Dutch small and medium enterprise markets and specializes in debt and equity financings for SMEs. Through a strategic alliance between us and Credion in which Credion’s extensive network of investors and entrepreneurs will be connected with each other through a new, online funding platform of ours. Credion will process the funding for its SME clients through our platform resulting in monthly recurring revenue and transaction fees for us. The alliance is intended to provide more efficient access to capital for SMEs while greatly improving SME data monitoring standards for investors. SMEs utilizing the platform will have direct access to Credion’s investor clients as well as our investors.
Financing proposals generated by Credion within the platform can be offered to investors (i) by means of a private placement with the professional financing parties affiliated by service level agreements or (ii) by means of an offer on the online direct funding platform enabling investors to invest online utilizing standardized financial products. For (i) above, the settlement of potential transactions will be finalized outside of the platform. For successful transactions under (ii) above, a percentage of the applicable success fee will be paid to Credion. Financiers will be encouraged, but not required, to purchase monitoring services from us. The financier will pay us a monthly fee for such monitoring services.
|
|
|
Kredietpaspoort Coöperatie UA
|
The Kredietpaspoort (Credit Passport) is an online “passport” which provides up-to date information about entrepreneurs and their business. The product is designed to be used by private investors to quickly assess the prospects and reliability of start-ups, SMEs and their owners before making an investment. In essence, the Credit Passport is a simple-to-use yet comprehensive online tool which provides the necessary information for all lenders.
|
|
Symbid Italia SPA
|
Through Symbid Italia, we intend to create a new online funding platform, based on our existing crowdfunding technology, in which Italian investors and entrepreneurs can connect, fund and grow together and to digitalize financial services for Italian small and medium enterprises. Symbid Italia represents the first stage of the European roll-out of our crowdfunding platform outside of The Netherlands.
|
|
|
Symbid Germany GmbH
|
Through Symbid Germany, we intend to create a new online funding platform, based on our existing crowdfunding technology, in which German investors and entrepreneurs can connect, fund and grow together and to digitalize financial services for German small and medium enterprises.
|
|
●
|
Application fees – $385 for every entrepreneur applying for funding through our online funding network, with part of such fee being utilized to purchase advisory services from Credion in its capacity as a preferred supplier
|
|
●
|
Transaction fees – For every payment transaction to a Symbid wallet or investment in an investment proposition, a fee of 1% is charged to the investor (1.21% including VAT).
|
|
●
|
Success fee – When reaching a funding target, 5% (exclusive of VAT) of the target capital is charged to the target company.
|
|
●
|
Placement fee – When reaching a funding target, a variable success fee is being charged to that target company.
|
|
●
|
Monitoring fees - Each financier will pay us a monthly fee of $10 (exclusive of VAT) for one monitoring portal access. Entrepreneurs will be charged a fee of $330 (exclusive VAT) for a monitoring start package which includes three portal accesses for the period of one year.
|
|
●
|
White label licenses
- Symbid offers stand-alone and white label versions of its crowdfunding platform to partners, companies and other (educational) organizations. Stand-alone versions of the crowdfunding platform operate independently in a closed environment while white label versions are interconnected with the Symbid crowdfunding platform allowing for interaction with Symbid platform users. Target net revenue per partner is $10,000 for the set-up and a yearly license fee to cover maintenance costs.
|
|
●
|
Software licenses
– Symbid offers exclusive licenses within a country to use the Symbid legal and technology infrastructure. Set-up fees are at a minimum of $27,000 and yearly license fees will be offered for a minimum of $10,000 per year;
|
|
●
|
Affiliate and Group licenses
– Symbid offers owners of existing communities or groups a crowdfunding service so they do not require their own crowdfunding infrastructure. Prices range from $530 to $2,500 on a yearly basis.
|
|
●
|
To serve a large base of people on any given platform, it is critical that Symbid can operate as matchmaker, much like a dating service, with the highest degree of accessibility possible;
|
|
●
|
Serious/professional investors will require a quality infrastructure and best practices, Symbid has been developing these best practices since its inception;
|
|
●
|
To offer an infrastructure which supports the financial model on a global scale and works for both entrepreneurs and investors;
|
|
●
|
Local responsiveness of Symbid is required in order to roll out the infrastructure on a global scale;
|
|
●
|
Partners, third-party analysts, researchers, potential suppliers and experts must be able to tap into and spread the content of the platform, much like is done for the public equity marketplace using social networks like Facebook and Twitter;
|
|
●
|
Standardized flows of information for both investors and entrepreneurs must be provided, to increase the efficiency of the transaction for all parties involved.
|
|
HOLDING LEVEL
|
COUNTRY LEVEL
|
|
|
Positioning strategy
|
Country sales
|
|
|
Product strategy
|
HR and Partner management
|
|
|
Partnering strategy
|
Country marketing
|
|
|
Acquisition strategy
|
Customer support
|
|
|
Financial planning
|
Event management
|
|
|
Execution plan
|
Proposition management
|
|
●
|
Attracting deals and investors;
|
|
●
|
Business (e)-valuation and monitoring;
|
|
●
|
Offering value added services for the companies; and
|
|
●
|
Offering value added services for the companies.
|
|
●
|
Access to a market with potentially large number of transactions;
|
|
●
|
Legal model compliant with local regulations;
|
|
●
|
Access to partner network of financial advisors or accountants (top-30 in a country);
|
|
●
|
Access to partnerships with incubators;
|
|
●
|
Access to partnerships with local business angel networks; and
|
|
●
|
Local team available with experience in corporate finance and business financing.
|
|
●
|
Symbid believes that the vision of crowdfunding is one of cooperation and people making things happen together. This vision is best expressed through a cooperative structure under Dutch law that embraces a vision of members working together for each other;
|
|
●
|
The cooperative structure provides the framework to more easily make our customers, entrepreneurs and investors, members of a community; and
|
|
●
|
The mechanics for adding new members to a Dutch cooperative enable us complete all Symbid related investment transactions over the internet, without any off-line interaction with investors.
|
|
●
|
Donation-based crowdfunding: donations made online to a specific project or cause without the prospect of any return;
|
|
●
|
Pre-sales (reward-based) crowdfunding: donations made online to a specific project or cause with the prospect of a return in the form of a product or service, when the project is successful;
|
|
●
|
Debt/loan crowdfunding (peer-to-peer and peer-to-business lending): investments made online in a specific loan proposal (business as well as private) with the prospect of a return in the form of interest and repayment of the initial debt;
|
|
●
|
Equity crowdfunding: investments made online in specific investment proposals with the prospect of a return in the form of dividends and value growth.
|
|
●
|
risks that we may not have sufficient capital to achieve our growth strategy;
|
|
●
|
risks that we may not develop our product and service offerings in a manner that enables us to be profitable and meet our customers’ requirements;
|
|
●
|
risks that our growth strategy may not be successful; and
|
|
●
|
risks that fluctuations in our operating results will be significant relative to our revenues.
|
|
●
|
that a broker or dealer approve a person’s account for transactions in penny stocks; and
|
|
●
|
the broker or dealer receives from the investor a written agreement to the transaction, setting forth the identity and quantity of the penny stock to be purchased.
|
|
●
|
obtain financial information and investment experience objectives of the person; and
|
|
●
|
make a reasonable determination that the transactions in penny stocks are suitable for that person and the person has sufficient knowledge and experience in financial matters to be capable of evaluating the risks of transactions in penny stocks.
|
|
●
|
the basis on which the broker or dealer made the suitability determination; and
|
|
●
|
that the broker or dealer received a signed, written agreement from the investor prior to the transaction.
|
|
●
|
generally, brokers may be less willing to execute transactions in securities subject to the “penny stock” rules. This may make it more difficult for investors to dispose of common stock and cause a decline in the market value of stock.
|
|
●
|
actual or anticipated variations in our operating results;
|
|
●
|
announcements of developments by us or our competitors;
|
|
●
|
announcements by us or our competitors of significant acquisitions, strategic partnerships, joint ventures or capital commitments;
|
|
●
|
adoption of new accounting standards affecting our Company’s industry;
|
|
●
|
additions or departures of key personnel;
|
|
●
|
sales of our common stock or other securities in the open market; and
|
|
●
|
other events or factors, many of which are beyond our control.
|
|
Period
|
High
|
Low
|
||||||
|
Quarter ended March 31, 2014
|
$
|
5.00
|
$
|
0.43
|
||||
|
Quarter ended June 30, 2014
|
4.25
|
1.20
|
||||||
|
Quarter ended September 30, 2014
|
2.00
|
0.35
|
||||||
|
Quarter ended December 31, 2014
|
0.75
|
0.18
|
||||||
|
Quarter ended March 31, 2015
|
0.34
|
0.18
|
||||||
|
Quarter ended June 30, 2015
|
0.33
|
0.16
|
||||||
|
Quarter ended September 30, 2015
|
0.30
|
0.15
|
||||||
|
Quarter ended December 31, 2015
|
0.37
|
0.191
|
||||||
|
Quarter ending March 31, 2016*
|
0.50
|
0.25
|
||||||
|
Plan category
|
Number of securities to be issued upon exercise of outstanding options, warrants, units and rights
|
Weighted-average exercise price of outstanding options, warrants, units and rights
|
Number of securities remaining available for future issuance under equity compensation plans (excluding securities reflected in column)
|
|||||||||
|
Equity compensation plans approved by security holders
(1)
|
518,222
|
N/A
|
3,356,542
|
|||||||||
|
Equity compensation plans not approved by security holders
|
N/A
|
N/A
|
N/A
|
|||||||||
|
Total
|
518,222
|
3,356,542
|
||||||||||
|
●
|
Options granted under the 2013 Plan entitle the grantee, upon exercise, to purchase a specified number of shares from us at a specified exercise price per share. The exercise price for shares of our Common Stock covered by an option generally cannot be less than the fair market value of our Common Stock on the date of grant unless agreed to otherwise at the time of the grant. In addition, in the case of an incentive stock option granted to an employee who, at the time the incentive stock option is granted, owns stock representing more than 10% of the voting power of all classes of stock of the Company or any parent or subsidiary, the per share exercise price will be no less than 110% of the fair market value of our Common Stock on the date of grant.
|
|
●
|
Restricted stock awards and restricted stock units may be awarded on terms and conditions established by the compensation committee, which may include performance conditions for restricted stock awards and the lapse of restrictions on the achievement of one or more performance goals for restricted stock units.
|
|
●
|
The Board of Directors may make performance grants, each of which will contain performance goals for the award, including the performance criteria, the target and maximum amounts payable, and other terms and conditions.
|
|
●
|
The 2013 Plan authorizes the granting of stock awards. The compensation committee will establish the number of shares of our Common Stock to be awarded and the terms applicable to each award, including performance restrictions.
|
|
●
|
Stock appreciation rights (“SARs”) entitle the participant to receive a distribution in an amount not to exceed the number of shares of our Common Stock subject to the portion of the SAR exercised multiplied by the difference between the market price of a share of our Common Stock on the date of exercise of the SAR and the market price of a share of our Common Stock on the date of grant of the SAR.
|
|
●
|
Consolidated revenue for the twelve month periods ended December 31, 2015 and 2014 totaled approximately $353,076 and $276,325, respectively, an increase of over 28%.
|
|
●
|
For the twelve months ended December 31, 2015, over 80% of our total revenues during this period was attributable to core online funding activities.
|
|
●
|
For the twelve month periods ended December 31, 2015 and 2014, total selling, general and administrative expenses totaled $1,543,827 and $2,166,028, respectively.
|
|
●
|
As of December 31, 2015 and 2014 we had 25 full-time employees.
|
|
●
|
Application fees – $370 (exclusive of VAT) for every entrepreneur applying for funding on The Funding Network, with part of such fee being utilized to purchase advisory services from Credion in its capacity as a preferred supplier
|
|
●
|
Transaction fees – For every payment transaction to a Symbid wallet or investment in an investment proposition, a fee of 1% (exclusive of VAT) is charged to the investor.
|
|
●
|
Refund Fee –If an investor requests a refund from the “Online Wallet” a fee is charged to the investor in the amount of approximately $22 (€ 20), of which the Company will receive approximately $5. As of December 1, 2014 the Company will be charged $16.5 for each refund by an investor, while for the investor a refund has become free of any charge.
|
|
●
|
Success fee – When reaching in an equity campaign the funding target, 5% (exclusive of VAT) of the target capital is charged to the target company. The loan based model operates through a transaction-based model similar to our current equity crowdfunding service. There is a fixed 1% success fee upon the successful funding of a loan crowdfunding campaign, paid by the business, plus 1% per year for the term of the loan immediately payable upon successful closing of the campaign.
|
|
●
|
Placement Fee - When reaching a funding target, a variable success fee is being charged to that target company.
|
|
●
|
Monitoring fees - The financer will pay us a monthly fee of $10 (exclusive of VAT) for one monitoring portal access. Entrepreneurs will be charged a fee of $320 (exclusive of VAT) for a monitoring start package which includes three portal accesses for one year.
|
|
●
|
White label licenses
- Symbid offers stand-alone and white label versions of its crowdfunding platform to partners, companies and other (educational) organizations. Stand-alone versions of the crowdfunding platform operate independently in a closed environment while white label versions are interconnected with the Symbid crowdfunding platform allowing for interaction with Symbid platform users. Target net revenue per partner is $10,000 for the set-up and a yearly license fee to cover maintenance costs.
|
|
●
|
Software licenses
– Symbid offers exclusive licenses within a country to use the Symbid legal and technology infrastructure. Set-up fees are at a minimum of $25,000 and yearly license fees will be offered for a minimum of $10,000 per year;
|
|
●
|
Affiliate and Group licenses
– Symbid offers owners of existing communities or groups a crowdfunding service so they do not require their own crowdfunding infrastructure. Prices range from $530 to $2,500 on a yearly basis.
|
|
Year Ended December 31,
|
||||||||
|
2015
|
2014
|
|||||||
|
Net Revenues
|
||||||||
|
Crowdfunding
|
$
|
282,155
|
$
|
267,358
|
||||
|
The Funding Network
|
47,975
|
-
|
||||||
|
Other
|
22,946
|
8,967
|
||||||
|
353,076
|
276,325
|
|||||||
|
Operating expenses
|
||||||||
|
Selling general and administrative
|
1,543,827
|
2,166,028
|
||||||
|
Professional fees
|
721,963
|
776,243
|
||||||
|
Research and development costs
|
59,930
|
320,032
|
||||||
|
Depreciation and amortization
|
145,543
|
70,517
|
||||||
|
Bad debt expense (recoveries)
|
36,292
|
(14,349
|
) | |||||
|
2,507,555
|
3,318,471
|
|||||||
|
Operating loss
|
(2,154,479)
|
(3,042,146
|
)
|
|||||
|
Other income (expenses)
|
||||||||
|
Fair value adjustment derivative liability – warrants
|
(7,791)
|
291,662
|
||||||
|
Interest expenses and amortization of debt discount
|
(148,509)
|
(31,405
|
)
|
|||||
|
Government subsidy
|
-
|
10,962
|
||||||
|
Gain on sale of investment in Gambitious B.V.
|
11,504
|
|||||||
|
Losses from equity method investments
|
-
|
(47,226
|
)
|
|||||
|
Other income and expense
|
-
|
(3,641
|
)
|
|||||
|
Total other income (expense)
|
(144,796)
|
220,352
|
||||||
|
Net loss
|
(2,299,275)
|
(2,821,794)
|
||||||
|
Net loss attributable to non-controlling interests
|
(99,761)
|
(28,794)
|
||||||
|
Net loss attributable to Symbid Corp. shareholders
|
$
|
(2,199,514)
|
$
|
(2,793,000)
|
||||
|
Basic and diluted loss per common share
|
$
|
(0.06)
|
$
|
(0.10
|
)
|
|||
|
Weighted average number of shares outstanding
|
||||||||
|
Basic and diluted
|
35,263,977
|
28,396,751
|
||||||
|
●
|
Pertain to the maintenance of records that in reasonable detail accurately and fairly reflect the transactions and dispositions of our assets;
|
|
●
|
Provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with accounting principles generally accepted in the United States of America and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and
|
|
●
|
Provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of our assets that could have a material effect on the financial statements.
|
|
●
|
Assuming we are able to secure additional working capital, we will create a position to segregate duties consistent with control objectives and will increase our personnel resources and technical accounting expertise within the accounting function when funds are available to us.
|
|
●
|
We also plan to create an audit committee which will undertake the oversight in the establishment and monitoring of required internal controls and procedures such as reviewing and approving estimates and assumptions made by management.
|
|
Name
|
Age
|
Position
|
Date Named to Board of Directors
|
|||
|
Korstiaan Zandvliet
|
31
|
Director, Chief Executive Officer and President
|
December 6, 2013
|
|||
|
Robin Slakhorst
|
32
|
Director, Chief Commercial Officer and Vice President
|
December 6, 2013
|
|||
|
Maarten van der Sanden
|
30
|
Chief Operating Officer and Secretary
|
N/A
|
|||
|
Dick Kooij
|
65
|
Chief Financial Officer and Treasurer
|
N/A
|
|||
|
Hendrik Kasteel
|
46
|
Director
|
July 15, 2015
|
|||
|
Michiel Buitelaar
|
53
|
Director
|
July 15, 2015
|
|||
|
Jérôme Koelewijn
|
49
|
Director
|
July 15, 2015
|
|||
|
Vincent Lui
|
42
|
Director
|
July 15, 2015
|
|
●
|
Any bankruptcy petition filed by or against any business of which such person was a general partner or executive officer either at the time of the bankruptcy or within two years prior to that time;
|
|
●
|
Any conviction in a criminal proceeding or being subject to a pending criminal proceeding (excluding traffic violations and other minor offences);
|
|
●
|
Being subject to any order, judgment, or decree, not subsequently reversed, suspended or vacated, of any court of competent jurisdiction, permanently or temporarily enjoining, barring, suspending or otherwise limiting his or her involvement in any type of business, securities or banking activities; or
|
|
●
|
Being found by a court of competent jurisdiction (in a civil action), the Commission or the Commodity Futures Trading Commission to have violated a federal or state securities or commodities law, and the judgment has not been reversed, suspended, or vacated.
|
|
Name & Principal Position
|
Fiscal Year ended
December 31,
|
Salary ($)
|
Bonus ($)
|
Stock Awards ($)
|
Option Awards ($)
|
Non-Equity Incentive Plan Compensation
|
Non-Qualified Deferred Compensation Earnings ($)
|
All Other Compensation ($)
|
Total ($)
|
|||||||||||||||||||||||||
|
Korstiaan Zandvliet, CEO(1)(3)
|
2015
|
$ | 60,396 | 0 | 29,542 | (4) | 0 | 0 | 0 | 0 | $ | 89,938 | ||||||||||||||||||||||
|
2014
|
$ | 98,406 | 0 | 26,839 | (2) | 0 | 0 | 0 | 0 | $ | 125,245 | |||||||||||||||||||||||
|
(1)
|
On December 6, 2013, Mr. Zandvliet, was appointed as our Chief Executive Officer and President.
|
|
(2)
|
Represents Stock Award compensation consisting of Restricted Stock Units awarded to the executive. As of July 24, 2014 the executive was awarded with 130,000 shares that all vested at the end of June 2015. As of December 31, 2014 we expensed $26,839 on these awards, which has been included in the calculation of the 2014 compensation for the executive.
|
|
(3)
|
The numbers presented in this table represent compensation paid to Mr. Zandvliet through his management entity, Arena Amnis B.V.
|
|
(4)
|
Represents Stock Award compensation consisting of Restricted Stock Units awarded to the executive. As of July 24, 2014 the executive was awarded with 130,000 shares that all vested at the end of June 2015. As of December 31, 2015 we expensed $30,361 on these awards, which has been included in the calculation of the 2015 compensation for the executive. As of November 5, 2015 the executive was awarded with 16,233 shares that will vest on November 5, 2016. As of December 31, 2015 we expensed $942 on these awards, which has been included in the calculation of the 2015 compensation for the executive.
|
|
Name and Address of Beneficial Owner
|
Common Stock
Beneficially Owned
|
Percent of Common Stock Beneficially Owned(1)
|
||||||
| Korstiaan Zandvliet | 1,337,799 | (2) | 3.62 | % | ||||
| Robin Slakhorst | 1,376,502 | (3) | 3.73 | % | ||||
| Maarten van der Sanden | 1,356,958 | (4) | 3.68 | % | ||||
| Dick Kooij | 0 | 0 | % | |||||
| Hendrik Kasteel | 332,150 | 0.90 | % | |||||
| Michiel Buitelaar | 49,984 | 0.14 | % | |||||
| Jérôme Koelewijn | 0 | 0 | % | |||||
| Vincent Lui | 100,000 | 0.27 | % | |||||
| All directors and executive officers as a group (8 persons) | 4,553,393 | 12.34 | % | |||||
| Maarten Timmerman | 2,060,896 | (5) | 5.58 | % | ||||
| Weerdsingel O.Z. 2 | ||||||||
| 3514 AA Utrecht, Netherlands | ||||||||
| Soops Investment B.V. | 1,950,178 | (6) | 5.28 | % | ||||
| Johan van Hasseltweg 43-2 | ||||||||
| 1021 KN Amsterdam, Netherlands | ||||||||
|
(1)
|
Applicable percentage ownership is based on 36,909,472 shares of Common Stock outstanding as of March 10, 2016, together with securities exercisable or convertible into shares of common stock within 60 days of March 10, 2016, for each shareholder. Beneficial ownership is determined in accordance with the rules of the SEC and generally includes voting or investment power with respect to securities. Shares of Common Stock issuable pursuant to the exercise or conversion of other securities are deemed outstanding for the purpose of computing the percentage of ownership of the security holder, but are not treated as outstanding for the purpose of computing the percentage of ownership of any other person.
|
|
(2)
|
Consists of shares of common stock held by Arena Amnis B.V. Korstiaan Zandvliet has sole voting and investment power with respect to these shares. Excludes up to 114,783 shares of Common Stock that are being held in escrow to secure the indemnification obligations of the former Symbid Holding B.V. shareholders under the Share Exchange Agreement.
|
|
(3)
|
Consists of shares of common stock held by Gastropoda Equus B.V. Robin Slakhorst has sole voting and investment power with respect to these shares. Excludes up to 118,461shares of Common Stock that are being held in escrow to secure the indemnification obligations of the former Symbid Holding B.V. shareholders under the Share Exchange Agreement.
|
|
(4)
|
Consists of shares of common stock held by Sanden Beheer B.V. Maarten van der Sanden has sole voting and investment power with respect to these shares. Excludes up to 116,604 shares of Common Stock that are being held in escrow to secure the indemnification obligations of the former Symbid Holding B.V. shareholders under the Share Exchange Agreement.
|
|
(5)
|
Consists of 101,548 shares of common stock held by Zomer B.V. and 1,769,348 shares of common stock held by Voyager Beheer B.V. Maarten Timmerman has 50% ownership with respect to the shares of Zomer B.V. and sole voting and investment power over the shares held by Voyager Beheer B.V. Excludes up to 274,467 shares of Common Stock that are being held in escrow to secure the indemnification obligations of the former Symbid Holding B.V. shareholders under the Share Exchange Agreement. Includes 190,000 shares of common stock issuable upon exercise of warrants which are currently exercisable.
|
|
(6)
|
Includes 162,850 shares of common stock issuable upon exercise of warrants which are currently exercisable.
|
|
Fee Category
|
Year ended
December 31,
2015
|
Year ended
December 31,
2014
|
||||||
|
Audit fees (1)
|
$
|
75,000
|
$
|
67,500
|
||||
|
Audit-related fees (2)
|
5,675
|
10,346
|
||||||
|
Tax fees (3)
|
0
|
0
|
||||||
|
All other fees (4)
|
0
|
0
|
||||||
|
Total fees
|
$
|
80,675
|
$
|
77,846
|
||||
|
(1)
|
Audit fees consist of fees incurred for professional services rendered for the audit of consolidated financial statements, for reviews of our interim consolidated financial statements included in our quarterly reports on Form 10-Q and for services that are normally provided in connection with statutory or regulatory filings or engagements.
|
|
(2)
|
Audit-related fees consist of fees billed for professional services that are reasonably related to the performance of the audit or review of our consolidated financial statements, but are not reported under “Audit fees.”
|
|
(3)
|
Tax fees consist of fees billed for professional services relating to tax compliance, tax planning, and tax advice.
|
|
(4)
|
All other fees consist of fees billed for all other services.
|
|
●
|
should not in all instances be treated as categorical statements of fact, but rather as a way of allocating the risk to one of the parties if those statements prove to be inaccurate;
|
|
●
|
have been qualified by disclosures that were made to the other party in connection with the negotiation of the applicable agreement, which disclosures are not necessarily reflected in the agreement;
|
|
●
|
may apply standards of materiality in a way that is different from what may be viewed as material to you or other investors; and
|
|
●
|
were made only as of the date of the applicable agreement or such other date or dates as may be specified in the agreement and are subject to more recent developments.
|
|
Exhibit Number
|
SEC Report Reference Number
|
Description
|
||
|
2.1
|
2.1
|
Share Exchange Agreement dated December 6, 2013, by and among Registrant, Symbid Holding B.V. and the Shareholders of Symbid Holding B.V (1)
|
||
|
3.1
|
3.1
|
Articles of Incorporation of the Registrant (2)
|
||
|
3.2
|
3.1
|
Certificate of Amendment to the Articles of Incorporation of the Registrant (3)
|
||
|
3.3
|
3.2
|
By-Laws of the Registrant (2)
|
||
|
3.4
|
3.4
|
Articles of Association of Symbid Cooperatie U.A. (Unofficial English Translation) (4)
|
||
|
3.5
|
3.5
|
Articles of Association of Symbid Foundation. (Unofficial English Translation) (4)
|
||
|
3.6
|
3.6
|
Articles of Association of Symbid IP Foundation. (Unofficial English Translation) (4)
|
||
|
4.1
|
4.1
|
Form of Investor Warrant of the Registrant (1)
|
||
|
4.2
|
4.2
|
Form of Broker Warrant of the Registrant (1)
|
||
|
4.3
|
4.1
|
Form of 2015 8% Convertible Promissory Note (9)
|
||
|
10.1
|
10.1
|
Split-Off Agreement, dated as of December 6, 2013, by and among the Registrant, Symbid Split Corp. and Holli Morris (1)
|
||
|
10.2
|
10.2
|
General Release Agreement, dated as of December 6, 2013, by and among the Registrant, Symbid Split Corp. and Holli Morris (1)
|
|
Exhibit Number
|
SEC Report Reference Number
|
Description
|
||
|
10.3
|
10.3
|
Form of Lock-Up and No Short Selling Agreement between the Registrant and the officers, directors and shareholders party thereto (1)
|
||
|
10.4
|
10.4
|
Form of Securities Purchase Agreement between the Registrant and the investors party thereto (1)
|
||
|
10.5
|
10.5
|
Form of Notice to Investors dated November 25, 2013 (1)
|
||
|
10.6
|
10.6
|
Placement Agency Agreement, dated September 9, 2013, between the Registrant and Gottbetter Capital Markets, LLC (1)
|
||
|
10.7
|
10.7
|
Placement Agency Agreement, First Amendment, dated October 14, 2013, between the Registrant and Gottbetter Capital Markets, LLC (1)
|
||
|
10.8
|
10.8
|
Placement Agency Agreement, Second Amendment, dated November 15, 2013, between the Registrant and Gottbetter Capital Markets, LLC (1)
|
||
|
10.9
|
10.9
|
Placement Agency Agreement, Third Amendment, dated February 6, 2014, between the Registrant and Gottbetter Capital Markets, LLC (6)
|
||
|
10.10
|
10.10
|
Placement Agency Agreement, Fourth Amendment, dated March 25, 2014, between the Registrant and Gottbetter Capital Markets, LLC (6)
|
||
|
10.11
|
10.11
|
Placement Agency Agreement, Fifth Amendment, dated April 30, 2014, between the Registrant and Gottbetter Capital Markets, LLC (6)
|
||
|
10.12
|
10.12
|
Placement Agency Agreement, Sixth Amendment, dated May 9, 2014, between the Registrant and Gottbetter Capital Markets, LLC (6)
|
||
|
10.13
|
10.9
|
Subscription Escrow Agreement, dated as of September 9, 2013, among the Registrant, CSC Trust Company of Delaware and Gottbetter Capital Markets, LLC (1)
|
||
|
10.14
|
10.10
|
Subscription Escrow Agreement, First Amendment dated as of November 15, 2013, among the Registrant, CSC Trust Company of Delaware and Gottbetter Capital Markets, LLC (1)
|
||
|
10.15
|
10.15
|
Subscription Escrow Agreement, Second Amendment dated as of February 6, 2014, among the Registrant, CSC Trust Company of Delaware and Gottbetter Capital Markets, LLC (6)
|
||
|
10.16
|
10.16
|
Subscription Escrow Agreement, Third Amendment dated as of March 25, 2014, among the Registrant, CSC Trust Company of Delaware and Gottbetter Capital Markets, LLC (6)
|
||
|
10.17
|
10.17
|
Subscription Escrow Agreement, Fourth Amendment dated as of April 30, 2014, among the Registrant, CSC Trust Company of Delaware and Gottbetter Capital Markets, LLC (6)
|
||
|
10.18
|
10.18
|
Subscription Escrow Agreement, Fifth Amendment dated as of May 9, 2014, among the Registrant, CSC Trust Company of Delaware and Gottbetter Capital Markets, LLC (6)
|
||
|
10.19
|
10.11
|
Escrow Agreement dated as of December 6, 2013 by and among the Registrant, the Indemnification and Shareholder Representative named therein and Gottbetter & Partners, LLP (1)
|
||
|
10.20
|
10.12
|
Employment Services Agreement, dated December 6, 2013, between the Registrant and Korstiaan Zandvliet (1)
|
||
|
10.21
|
10.13
|
Employment Services Agreement, dated December 6, 2013, between the Registrant and Robin Slakhorst (1)
|
||
|
10.22
|
10.14
|
Employment Services Agreement, dated December 6, 2013, between the Registrant and Maarten van der Sanden (1)
|
|
Exhibit Number
|
SEC Report Reference Number
|
Description
|
||
|
10.23
|
10.1
|
Employment Services Agreement, dated April 15, 2014 between the Registrant and Philip Cooke (5)
|
||
|
10.24
|
10.15
|
Registrant’s 2013 Equity Incentive Plan (1)
|
||
|
10.25
|
10.16
|
Form of Registration Rights Agreement (1)
|
||
|
10.26
|
10.17
|
License Agreement dated April 13, 2011 by and between Symbid B.V. and Symbid Cooperatie U.A. (1)
|
||
|
10.27
|
10.18
|
Platform Management Services Agreement April 6, 2011 by and between Symbid B.V. and Symbid Cooperatie U.A. (1)
|
||
|
10.28
|
10.19
|
Intellectual Property Transfer Agreement dated October 16, 2013 by and between Symbid B.V. and Stichting Symbid IP Foundation (1)
|
||
|
10.29
|
10.20
|
Intellectual Property License and Transfer Agreement dated October 16, 2013 by and between Stichting Symbid IP Foundation and Symbid Holding B.V. (1)
|
||
|
10.30
|
10.21
|
Addendum 1 dated December 5, 2013 to Intellectual Property License and Transfer Agreement dated October 16, 2013 by and between Stichting Symbid IP Foundation and Symbid Holding B.V. (1)
|
||
|
10.31
|
10.22
|
Intellectual Property Sublicense and Transfer Agreement dated December 5, 2013 by and between Symbid Holding B.V. and Symbid B.V. (1)
|
||
|
10.32
|
10.1
|
Share Purchase Agreement dated July 29, 2014, between the Registrant, Symbid Holding B.V., and FAC 2 B.V (7)
|
||
|
10.33
|
10.25
|
Agreement dated December 8, 2014 by and between the Registrant and Fortion Holding B.V. (8)
|
||
|
10.34
|
10.26
|
Subscription and shareholder agreement dated December, 2014, between the Registrant, Banca Sella Holding SPA and Marco Bicocchi Pichi (8)
|
||
|
10.35
|
10.1
|
Employment Services Agreement dated as of November 1, 2015 between Registrant and Dick Kooij (10)
|
||
|
10.36
|
10.2
|
Amendment No. 1 dated as of November 16, 2015 to Employment Services Agreement between Registrant and Dick Kooij (10)
|
||
|
10.37
|
10.1
|
Financial Public Relations Agreement dated as of July 1, 2015 between Registrant and Dynasty Wealth LLC (11)
|
||
|
10.38
|
10.1
|
First Amendment dated as of November 11, 2015 to Financial Public Relations Agreement dated as of July 1, 2015 between Registrant and Dynasty Wealth LLC (9)
|
||
|
10.39
|
10.2
|
Form of Restricted Stock Unit Agreement of Registrant (12)
|
||
|
14.1
|
14.1
|
Code of Ethics (2)
|
||
|
21.1
*
|
Subsidiaries of Registrant
|
|||
|
23.1
*
|
Consent of Independent Registered Public Accounting Firm
|
|||
|
31.1
*
|
Certification of Principal Executive Officer pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002**
|
|||
|
31.2
*
|
Certification of Principal Financial Officer pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002**
|
|||
|
32.1
*
|
Certifications of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002**
|
|
Exhibit Number
|
SEC Report Reference Number
|
Description
|
||
|
32.2
*
|
Certifications of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002**
|
|||
|
101.INS*
|
XBRL Instance Document***
|
|||
|
101.SCH*
|
XBRL Taxonomy Extension Schema Document***
|
|||
|
101.CAL*
|
XBRL Taxonomy Extension Calculation Linkbase Document***
|
|||
|
101.DEF*
|
XBRL Taxonomy Extension Definition Linkbase Document***
|
|||
|
101.LAB*
|
XBRL Taxonomy Extension Label Linkbase Document***
|
|
(1)
|
Filed with the Securities and Exchange Commission on December 12, 2013, as an exhibit, numbered as indicated above, to the Registrant’s Current Report on Form 8-K dated December 6, 2013, which exhibit is incorporated herein by reference.
|
|
(2)
|
Filed with the Securities and Exchange Commission on October 25, 2011, as an exhibit, numbered as indicated above, to the Registrant’s Registration Statement on Form S-1 (File No. 333-177500), which exhibit is incorporated herein by reference.
|
|
(3)
|
Filed with the Securities and Exchange Commission on September 9, 2013, as an exhibit, numbered as indicated above, to the Registrant’s Current Report on Form 8-K dated September 3, 2013, which exhibit is incorporated herein by reference.
|
|
(4)
|
Filed with the Securities and Exchange Commission on March 13, 2014, an exhibit, numbered as indicated above, to the Registrant’s Current Report on Form 8-K/A (Amendment No. 1) dated December 6 , 2013, which exhibit is incorporated herein by reference.
|
|
(5)
|
Filed with the Securities and Exchange Commission on April 18, 2014, as an exhibit, numbered as indicated above , to the Registrant’s Current Report on Form 8-K, which exhibit is incorporated herein by reference.
|
|
(6)
|
Filed with the Securities and Exchange Commission on May 21, 2014, as an exhibit, numbered as indicated above, to the Registrant’s Registration Statement on Form S-1 (File No. 333-196153), which exhibit is incorporated herein by reference.
|
|
(7)
|
Filed with the Securities and Exchange Commission on August 4, 2014, as an exhibit, numbered as indicated above, to the Registrant’s Current Report on Form 8-K dated July 29, 2014, which exhibit is incorporated herein by reference.
|
|
(8)
|
Filed with the Securities and Exchange Commission on March 25, 2015, as an exhibit, numbered as indicated above, to the Registrant’s Annual Report on Form 10-K for the year ended December 31, 2014, which exhibit is incorporated herein by reference.
|
|
(9)
|
Filed with the Securities and Exchange Commission on November 12, 2015, as an exhibit, numbered as indicated above, to the Registrant's Quarterly Report on Form 10-Q for the quarter ended September 30, 2015, which exhibit is incorporated herein by reference.
|
|
(10)
|
Filed with the Securities and Exchange Commission on November 19, 2015, as an exhibit, numbered as indicated above, to the Registrant's Current Report on Form 8-K dated November 16, 2015, which exhibit is incorporated herein by reference.
|
|
(11)
|
Filed with the Securities and Exchange Commission on July 8, 2015, as an exhibit, numbered as indicated above, to the Registrant's Current Report on Form 8-K dated July 1, 2015, which exhibit is incorporated herein by reference.
|
|
(12)
|
Filed with the Securities and Exchange Commission on July 31, 2015, as an exhibit, numbered as indicated above, to the Registrant’s Registration Statement on Form S-8, which exhibit is incorporated herein by reference.
|
|
SYMBID CORP.
|
|||
|
Dated: March 25, 2016
|
By:
|
/s/ Korstiaan Zandvliet
|
|
|
Name
|
Korstiaan Zandvliet
|
||
|
Title
|
Chief Executive Officer and President
|
||
|
(Principal Executive Officer)
|
|||
|
Dated: March 25, 2016
|
By:
|
/s/ Dick Kooij
|
|
|
Name
|
Dick Kooij
|
||
|
Title
|
Chief Financial Officer
|
||
|
(Principal Financial Officer)
|
|||
|
Signature
|
Title
|
Date
|
||
|
/s/ Korstiaan Zandvliet
|
Chief Executive Officer and President (Principal
|
March 25, 2016
|
||
|
Korstiaan Zandvliet
|
Executive Officer) and Director
|
|||
|
/s/ Robin Slakhorst
|
Vice President and Director
|
March 25, 2016
|
||
|
Robin Slakhorst
|
||||
|
/s/ Hendrik Kasteel
|
Director
|
March 25, 2016
|
||
|
Hendrik Kasteel
|
||||
|
/s/ Michiel Buitelaar
|
Director
|
March 25, 2016
|
||
|
Michiel Buitelaar
|
||||
|
/s/
Jérôme
Koelewijn
|
Director
|
March 25, 2016
|
||
|
Jérôme Koelewijn
|
||||
|
/s/ Vincent Lui
|
Director
|
March 25, 2016
|
||
|
Vincent Lui
|
||||
|
Page
|
|
|
Report of Independent Registered Public Accounting Firm
|
F-1
|
|
Consolidated Balance Sheets as of December 31, 2015 and 2014
|
F-2
|
|
Consolidated Statements of Operations for the Years Ended December 31, 2015 and 2014
|
F-3
|
|
Consolidated Statements of Comprehensive Loss for the Years Ended December 31, 2015 and 2014
|
F-4
|
|
Consolidated Statements of Stockholders’ Equity (Deficit) for the years ended December 31, 2015 and 2014
|
F-5
|
|
Consolidated Statements of Cash Flows for the Years Ended December 31, 2015 and 2014
|
F-6
|
|
Notes to Consolidated Financial Statements
|
F-7
|
|
East Hanover, New Jersey
|
|
|
March 25, 2016
|
|
|
December 31,
|
December 31,
|
|||||||
|
2015
|
2014
|
|||||||
|
ASSETS
|
||||||||
|
Current assets
|
||||||||
|
Cash
|
$
|
553,696
|
$
|
233,068
|
||||
|
Accounts receivable, less allowance for doubtful accounts of $39,847 and $4,672 respectively
|
64,639
|
45,070
|
||||||
|
Prepaid expenses and other current assets
|
42,553
|
53,366
|
||||||
|
Total current assets
|
660,888
|
331,504
|
||||||
|
Property and equipment, at cost, less accumulated depreciation
|
15,108
|
8,480
|
||||||
|
Investments in associated companies
|
1,134
|
10,750
|
||||||
|
Intangible assets, net
|
785,070
|
1,031,692
|
||||||
|
Total assets
|
$
|
1,462,200
|
$
|
1,382,426
|
||||
|
LIABILITIES AND STOCKHOLDERS' EQUITY
|
||||||||
|
Current liabilities
|
||||||||
|
Accounts payable
|
$
|
88,774
|
$
|
378,023
|
||||
|
Accrued expenses and other current liabilities
|
301,896
|
291,540
|
||||||
|
Current maturities of notes payable
|
32,993
|
36,771
|
||||||
|
Subordinated loan – related party
|
73,016
|
81,378
|
||||||
|
Total current liabilities
|
496,679
|
787,712
|
||||||
|
Notes payable, less current maturities
|
49,476
|
91,914
|
||||||
|
8% Convertible promissory notes payable, net of $722,622 discount
|
587,378
|
-
|
||||||
|
Derivative liability – warrants
|
-
|
153,154
|
||||||
|
Total liabilities
|
1,133,533
|
1,032,780
|
||||||
|
Commitments
|
||||||||
|
Stockholders' Equity
|
||||||||
|
Preferred stock
|
||||||||
|
Authorized: $0.001 par value, 10,000,000 shares authorized
|
-
|
-
|
||||||
|
Issued and outstanding: nil preferred shares
|
||||||||
|
Common stock
|
||||||||
|
Authorized: $0.001 par value, 290,000,000 shares authorized
|
||||||||
|
Issued and outstanding: 36,909,472 and 33,182,100 respectively
|
36,909
|
33,182
|
||||||
|
Additional paid-in capital
|
7,635,104
|
5,367,771
|
||||||
|
Accumulated other comprehensive loss
|
(322,183
|
)
|
(178,522
|
)
|
||||
|
Accumulated deficit
|
(6,994,274
|
)
|
(4,794,760
|
)
|
||||
|
Total Symbid Corp. stockholders' equity
|
355,556
|
427,671
|
||||||
|
Noncontrolling interests
|
(26,889
|
)
|
(78,025
|
)
|
||||
|
Total stockholders' equity
|
328,667
|
349,646
|
||||||
|
Total liabilities and stockholders' equity
|
$
|
1,462,200
|
$
|
1,382,426
|
||||
|
Year ended
|
||||||||
|
December 31,
|
||||||||
|
2015
|
2014
|
|||||||
|
Revenues
|
||||||||
|
Crowdfunding
|
$
|
282,155
|
$
|
267,358
|
||||
|
The Funding Network
|
47,975
|
-
|
||||||
|
Other
|
22,946
|
8,967
|
||||||
|
Total revenues
|
353,076
|
276,325
|
||||||
|
Operating expenses
|
||||||||
|
Selling, general and administrative
|
1,543,827
|
2,166,028
|
||||||
|
Professional fees
|
721,963
|
776,243
|
||||||
|
Research and development costs
|
59,930
|
320,032
|
||||||
|
Depreciation and amortization
|
145,543
|
70,517
|
||||||
|
Bad debt expense (recoveries)
|
36,292
|
(14,349
|
)
|
|||||
|
Total operating expenses
|
2,507,555
|
3,318,471
|
||||||
|
Operating loss
|
(2,154,479
|
)
|
(3,042,146
|
)
|
||||
|
Other income (expense)
|
||||||||
|
Fair value adjustment derivative liability – warrants
|
(7,791
|
)
|
291,662
|
|||||
|
Interest expense and amortization of debt discount
|
(148,509
|
)
|
(31,405
|
)
|
||||
|
Government subsidy
|
-
|
10,962
|
||||||
|
Gain on sale of investment in Gambitious B.V.
|
11,504
|
-
|
||||||
|
Losses from equity method investments
|
-
|
(47,226
|
)
|
|||||
|
Other income and expense
|
-
|
(3,641
|
)
|
|||||
|
Total other expense
|
(144,796
|
)
|
220,352
|
|
||||
|
Net loss
|
(2,299,275
|
)
|
(2,821,794
|
)
|
||||
|
Net loss attributable to noncontrolling interests
|
(99,761
|
)
|
(28,794
|
)
|
||||
|
Net loss attributable to Symbid Corp. stockholders
|
$
|
(2,199,514
|
)
|
$
|
(2,793,000
|
)
|
||
|
Basic and diluted net loss per common share
|
$
|
(0.06
|
)
|
$
|
(0.10
|
)
|
||
|
Weighted average number of shares outstanding
|
||||||||
|
Basic and diluted
|
35,263,977
|
28,396,751
|
||||||
|
Share-based compensation expense included in operating expenses:
|
||||||||
|
Selling, general and administrative
|
$
|
286,298
|
$
|
832,827
|
||||
|
Professional fees
|
152,711
|
139,455
|
||||||
|
Research and development costs
|
33,791
|
5,029
|
||||||
|
$
|
472,800
|
$
|
977,311
|
|||||
|
Year ended
|
||||||||
|
December 31,
|
||||||||
|
2015
|
2014
|
|||||||
|
Net loss
|
$
|
(2,299,275
|
)
|
$
|
(2,821,794
|
)
|
||
|
Other comprehensive loss:
|
||||||||
|
Foreign currency translation adjustments
|
(143,661
|
)
|
(134,493
|
)
|
||||
|
Comprehensive loss
|
(2,442,936
|
)
|
(2,956,287
|
)
|
||||
|
Net loss attributable to noncontrolling interests
|
(99,761
|
)
|
(28,794
|
)
|
||||
|
Foreign currency translation income (loss) attributable to noncontrolling interests
|
10,129
|
10,366
|
||||||
|
Comprehensive loss attributable to noncontrolling interests
|
(89,632
|
)
|
(18,428
|
)
|
||||
|
Comprehensive loss attributable to Symbid Corp. stockholders
|
$
|
(2,353,304
|
)
|
$
|
(2,937,859
|
)
|
||
|
Symbid Corp. Stockholders’
|
||||||||||||||||||||||||||||||||
|
Number of
Shares
|
Common
Stock
|
Additional
Paid-In
Capital
|
Accumulated
Other
Comprehensive
Loss
|
Accumulated
Deficit
|
Total Symbid Corp.
Stockholders'
Equity
|
Noncontrolling
Interests
|
Total
Stockholders'
Equity
|
|||||||||||||||||||||||||
|
Balance, January 1, 2014
|
34,268,736 | 34,268 | 2,041,052 | (44,029 | ) | (2,001,760 | ) | 29,531 | (59,597 | ) | (30,066 | ) | ||||||||||||||||||||
|
Proceeds from the issuance of common stock, net of issuance costs
|
2,754,794 | 2,755 | 1,102,518 | - | - | 1,105,273 | - | 1,105,273 | ||||||||||||||||||||||||
|
Cancellation of Gambitious and Equidam Escrow Shares
|
(8,300,000 | ) | (8,300 | ) | 8,300 | - | - | - | - | - | ||||||||||||||||||||||
|
Issuance of common stock for services
|
208,570 | 209 | 97,011 | - | - | 97,220 | - | 97,220 | ||||||||||||||||||||||||
|
Issuance of common stock for assets
|
2,750,000 | 2,750 | 1,192,342 | - | - | 1,195,092 | - | 1,195,092 | ||||||||||||||||||||||||
|
Reclassification of warrants
|
- | - | 123,569 | - | - | 123,569 | - | 123,569 | ||||||||||||||||||||||||
| Share Based compensation related to employee share based awards | - | - | 159,479 | - | - | 159,479 | - | 159,479 | ||||||||||||||||||||||||
| Fortion Holding B.V. - Shares issued under Strategic Alliance Agreement | 1,500,000 | 1,500 | 643,500 | - | - | 645,000 | 645,000 | |||||||||||||||||||||||||
|
Translation adjustment
|
- | - | - | (134,493 | ) | - | (134,493 | ) | 10,366 | (124,127 | ) | |||||||||||||||||||||
|
Net loss
|
- | - | - | - | (2,793,000 | ) | (2,793,000 | ) | (28,794 | ) | (2,821,794 | ) | ||||||||||||||||||||
|
Balance, December 31, 2014
|
33,182,100 | 33,182 | 5,367,771 | (178,522 | ) | (4,794,760 | ) | 427,671 | (78,025 | ) | 349,646 | |||||||||||||||||||||
|
Proceeds from the issuance of common stock, net of issuance costs
|
1,448,232 | 1,448 | 722,668 | - | - | 724,116 | - | 724,116 | ||||||||||||||||||||||||
|
Issuance of common stock for services
|
530,904 | 531 | 181,856 | - | - | 182,387 | - | 182,387 | ||||||||||||||||||||||||
|
Reclassification of warrants
|
- | - | 160,945 | - | - | 160,945 | - | 160,945 | ||||||||||||||||||||||||
|
Share Based compensation related to employee share based awards
|
988,236 | 988 | 320,166 | - | - | 321,154 | - | 321,154 | ||||||||||||||||||||||||
|
Symbid Italia formation
|
- | - | (129,918 | ) | - | - | (129,918 | ) | 140,768 | 10,850 | ||||||||||||||||||||||
|
Conversion of 8% Notes
|
760,000 | 760 | 189,240 | - | - | 190,000 | - | 190,000 | ||||||||||||||||||||||||
|
Beneficial conversion feature
|
- | - | 822,376 | - | - | 822,376 | - | 822,376 | ||||||||||||||||||||||||
|
Translation adjustment
|
- | - | - | (143,661 | ) | - | (143,661 | ) | 10,129 | (133,532 | ) | |||||||||||||||||||||
|
Net loss
|
- | - | - | - | (2,199,514 | ) | (2,199,514 | ) | (99,761 | ) | (2,299,275 | ) | ||||||||||||||||||||
|
Balance, December 31, 2015
|
36,909,472 | $ | 36,909 | $ | 7,635,104 | $ | (322,183 | ) | $ | (6,994,274 | ) | $ | 355,556 | $ | (26,889 | ) | $ | 328,667 | ||||||||||||||
|
Year ended
|
||||||||
|
December 31,
|
December 31,
|
|||||||
|
Cash flows from operating activities
|
2015
|
2014
|
||||||
|
Net loss
|
$
|
(2,299,275
|
)
|
$
|
(2,821,794
|
)
|
||
|
Adjustments to reconcile net loss to net cash
|
||||||||
|
used in operating activities
|
||||||||
|
Employee and non-employee stock based compensation
|
320,089
|
159,479
|
||||||
|
Shares issued under strategic alliance agreement
|
-
|
645,000
|
||||||
|
Stock issued for services
|
182,387
|
97,220
|
||||||
|
Depreciation and amortization
|
145,543
|
70,517
|
||||||
|
Amortization of debt discount
|
99,753
|
-
|
||||||
|
Equity in losses of Gambitious and Kredietpaspoort
|
-
|
47,225
|
||||||
|
Warrant liability - fair value adjustment
|
7,791
|
(291,662
|
)
|
|||||
|
Provision for doubtful accounts
|
36,292
|
(14,349
|
)
|
|||||
|
Gain on sale of investment in Gambitious B.V.
|
(11,504
|
)
|
-
|
|||||
|
Deferred government grants
|
-
|
(10,963
|
)
|
|||||
|
Changes in assets and liabilities
|
||||||||
|
Accounts receivable
|
(60,926
|
)
|
(31,632
|
)
|
||||
|
Prepaid expenses and other current assets
|
5,431
|
(928
|
)
|
|||||
|
Accounts payable
|
(262,073
|
)
|
270,297
|
|||||
|
Accrued Expenses and other current liabilities
|
33,449
|
61,138
|
||||||
|
Net cash used in operating activities
|
(1,803,043
|
)
|
(1,820,452
|
)
|
||||
|
Cash flows from investing activities
|
||||||||
|
Investment in associated companies
|
$
|
-
|
$
|
(57,306
|
)
|
|||
|
Proceeds from sale of investment in Gambitious B.V.
|
20,309
|
-
|
||||||
|
Acquisition of property and equipment
|
(9,885
|
)
|
(6,857)
|
|||||
|
Net cash provided by (used in) investing activities
|
10,424
|
(64,163
|
)
|
|||||
|
Cash flows from financing activities
|
||||||||
|
Proceeds from 8% convertible promissory notes payable
|
$
|
1,500,000
|
$
|
-
|
||||
|
Proceeds from the issuance of common stock, net of issuance costs
|
724,116
|
1,369,996
|
||||||
|
Repayments of notes payable
|
(33,583
|
)
|
(39,769
|
)
|
||||
|
Net cash provided by financing activities
|
2,190,533
|
1,330,227
|
||||||
|
Effect of exchange rate changes on cash
|
(77,286
|
)
|
(104,136
|
)
|
||||
|
Net (decrease) / increase in cash
|
320,628
|
(658,524)
|
||||||
|
Cash and cash equivalents, beginning of year
|
233,068
|
891,592
|
||||||
|
Cash and cash equivalents, end of year
|
$
|
553,696
|
$
|
233,068
|
||||
|
Supplemental cash flow disclosures
|
||||||||
|
Interest paid
|
$
|
(13,609
|
)
|
$
|
(31,405
|
)
|
||
|
Non-cash investing and financing activities
|
||||||||
|
Change in accrued expenses related to non-employee share based payments
|
$
|
1,065
|
$
|
76,208
|
||||
|
Reallocation of noncontrolling interests
|
129,918
|
-
|
||||||
|
Conversion of 8% convertible promissory notes
|
190,000
|
-
|
||||||
|
Fair value of shares issued related to acquisitions of assets
|
-
|
1,195,092
|
||||||
|
Fair value of warrant liability recorded
|
-
|
264,723
|
||||||
|
●
|
Limited or no structured distribution channels for SME finance other than banks, increasing the mismatch between entrepreneurs and financiers;
|
|
●
|
No centralized platform for (alternative) financiers, making it difficult and inefficient to find the right financier at the right time;
|
|
●
|
No standardized data protocols for SME data, leading to costly and time-intensive (offline) screening and monitoring;
|
|
●
|
Limited financial skills of entrepreneurs leading to unnecessary inefficiencies and obstacles within the financing process; and
|
|
●
|
Decline in bank financing due to new regulations and recent financial crises, leaving a vacuum in the life cycle of SME financing.
|
|
December 31,
|
||||||||
|
2015
|
2014
|
|||||||
|
Current assets
|
$
|
73,600
|
$
|
43,497
|
||||
|
Current liabilities
|
$
|
186,214
|
$
|
121,521
|
||||
|
December 31,
|
||||||||
|
Prepaid expenses and other current assets
|
2015
|
2014
|
||||||
|
VAT return Q4 2015/ 2014
|
$
|
17,827
|
$
|
44,146
|
||||
|
Revenues to be invoiced
|
2,472
|
1,173
|
||||||
|
Other prepaid expenses
|
10,883
|
8,047
|
||||||
|
Insurance premiums
|
11,371
|
-
|
||||||
|
$
|
42,553
|
$
|
53,366
|
|||||
|
December 31,
|
||||||||
|
2015
|
2014
|
|||||||
|
Computers and equipment
|
$
|
20,868
|
$
|
12,288
|
||||
|
Less - Accumulated depreciation
|
(5,760
|
)
|
(3,808
|
)
|
||||
|
$
|
15,108
|
$
|
8,480
|
|||||
|
December 31,
|
||||||||
|
2015
|
2014
|
|||||||
|
Software
|
$
|
984,267
|
$
|
1,100,453
|
||||
|
Less - Accumulated amortization
|
(199,197
|
)
|
(68,762
|
)
|
||||
|
$
|
785,070
|
$
|
1,031,691
|
|||||
|
Years ending December 31,
|
||||
|
2016
|
140,610
|
|||
|
2017
|
140,610
|
|||
|
2018
|
140,610
|
|||
|
2019
|
140,610
|
|||
|
2020
|
140,610
|
|||
|
Thereafter
|
82,020
|
|||
|
$
|
785,070
|
|||
|
December 31,
|
||||||||
|
2015
|
2014
|
|||||||
|
Advisory costs
|
$
|
89,829
|
$
|
44,591
|
||||
|
Interest
|
45,863
|
10,717
|
||||||
|
Wage tax return
|
19,035
|
17,992
|
||||||
|
Holiday pay allowance/Net salary
|
24,533
|
53,555
|
||||||
|
Penalty waiver
|
14,630
|
14,630
|
||||||
|
Marketing
|
38,069
|
70,347
|
||||||
|
Accrued stock liability
|
20,541
|
21,841
|
||||||
|
Development costs
|
-
|
14,174
|
||||||
|
Management fee
|
-
|
11,190
|
||||||
|
VAT related to Symbid Coop.
|
-
|
10,828
|
||||||
|
Other current liabilities
|
49,396
|
21,675
|
||||||
|
$
|
301,896
|
$
|
291,540
|
|||||
|
December 31,
|
||||||||
|
2015
|
2014
|
|||||||
|
Line of credit
|
$
|
-
|
$
|
-
|
||||
|
Working capital facility
|
82,469
|
128,685
|
||||||
|
Subordinated loan – related party
|
73,016
|
81,378
|
||||||
|
8% Convertible promissory notes
|
587,378
|
-
|
||||||
|
Total notes payable
|
742,863
|
210,063
|
||||||
|
Less - Current Maturities
|
(106,009
|
)
|
(118,149
|
)
|
||||
|
Notes payable, less current maturities
|
$
|
636,854
|
$
|
91,914
|
||||
| 1. | Long term loan for approximately $198,000, bears interest of 6.4%, principal and interest is payable quarterly. The loan is paid on a quarterly basis in increments of approximately $8,000, starting on September 30, 2012. As of December 31, 2015, the loan balance was approximately $82,000. | |
| 2. | A line of credit of approximately $65,000 with a floating interest rate of approximately 8.4% and 8.15% at December 31, 2015 and December 31, 2014, respectively. There was no balance on the credit facility at December 31, 2015. |
| 1. |
Assets of the Company including receivables and intellectual property developed by the Company.
|
|
| 2. |
Guarantee by principal members of management up to approximately $55,000.
|
|
| 3. |
Guarantee by the Netherlands government for the remaining balance in a hypothetical liquidation up to approximately $237,000.
|
|
|
Principal
|
Accrued Interest
|
Debt Discount
|
Balance
As of
December
31,
2015
|
||||||||||||
|
8% Convertible promissory notes July 14, 2015
|
|
$
|
60,000
|
|
$
|
2,213
|
|
$
|
(12,964)
|
|
$
|
49,249
|
|
|||
|
8% Convertible promissory notes September 8, 2015
|
1,250,000
|
31,111
|
(709,658)
|
571,453
|
||||||||||||
|
|
$
|
1,310,000
|
$
|
33,324
|
$
|
(722,622
|
)
|
$
|
620,702
|
|||||||
|
Year ending December 31,
|
||||
|
2016
|
$
|
106,009
|
||
|
2017
|
32,993
|
|||
|
2018
|
1,326,483
|
|||
|
$
|
1,465,485
|
|||
|
Gross proceeds from the PPO
|
$
|
1,377,392
|
||
|
Issuance costs
|
(7,750
|
)
|
||
|
Proceeds allocated to warrant liability
|
(
264,369
|
)
|
||
|
Proceeds allocated to common stock
|
$
|
1,105,273
|
|
Year Ended
December 31,
|
||||||||
|
2015
|
2014
|
|||||||
|
Symbid Coop- 100%
|
$ | 43,202 | $ | 28,794 | ||||
|
Symbid Italia – 49.9%
|
56,559 | - | ||||||
|
Total net loss attributable to NCI
|
$ | 99,761 | $ | 28,794 | ||||
|
Year Ended
December 31,
|
||||||||
|
2015
|
2014
|
|||||||
|
Symbid Coop- 100%
|
$ | (112,614 | ) | $ | (78,025 | ) | ||
|
Symbid Italia – 49.9%
|
85,725 | -- | ||||||
|
Total equity (deficit) attributable to noncontrolling interests
|
$ | (26,889 | ) | $ | (78,025 | ) | ||
|
|
December 31,
|
|||
|
|
2014
|
|||
|
Investor Warrants
|
||||
|
Implied starting stock price
|
$
|
0.40
|
||
|
Volatility
|
50
|
%
|
||
|
Drift
|
0.64%-0.84
|
%
|
||
|
Exercise price
|
$
|
0.75
|
||
|
Minimum exercise price
|
$
|
0.01
|
||
|
Warrant shares
|
5,853,530
|
|||
|
Event date
|
January 31, 2015
|
|||
|
Maturity
|
December 5, 2016 – May 20, 2017
|
|||
|
Shares outstanding
|
33,182,100
|
|||
|
|
December 31,
|
|||
|
|
2014
|
|||
|
Broker Warrants
|
||||
|
Implied starting stock price
|
$
|
0.40
|
||
|
Volatility
|
50
|
%
|
||
|
Drift
|
0.64%-0.71
|
%
|
||
|
Exercise price
|
$
|
0.50
|
||
|
Minimum exercise price
|
$
|
0.01
|
||
|
Warrant shares
|
93,000
|
|||
|
Event date
|
January 31, 2015
|
|||
|
Maturity
|
December 5, 2016- February 5, 2017
|
|||
|
Shares outstanding
|
33,182,100
|
|||
|
Year Ended December 31, 2015
|
||||||||||||||||||||
|
December 31, 2014 Fair Value of Warrant Liability
|
Fair Value of Warrants Issued
|
Change in Fair value of Warrant Liabilities
|
Reclassification
of Warrants
to Equity at
December,
31, 2015
|
December 31, 2015 Fair Value of Warrant Liability
|
||||||||||||||||
|
Investor Warrants
|
$
|
151,763
|
$
|
-
|
$
|
7,791
|
$
|
(159,554
|
)
|
$
|
-
|
|||||||||
|
Broker Warrants
|
1,391
|
-
|
-
|
(1,391
|
)
|
-
|
||||||||||||||
|
Total
|
$
|
153,154
|
$
|
-
|
$
|
7,791
|
$
|
(160,945
|
)
|
$
|
-
|
|||||||||
|
Year Ended December 31, 2014
|
||||||||||||||||||||
|
December 31, 2013 Fair Value of Warrant Liability
|
Fair Value of Warrants Issued
|
Change in Fair value of Warrant Liabilities
|
Reclassification
of Warrants
to Equity at
December,
31, 2014
|
December 31, 2014 Fair Value of Warrant Liability
|
||||||||||||||||
|
Investor Warrants
|
$
|
294,298
|
$
|
262,521
|
$
|
(287,723
|
)
|
$
|
(117,333
|
)
|
$
|
151,763
|
||||||||
|
Broker Warrants
|
9,364
|
1,854
|
(3,939
|
)
|
(6,236
|
)
|
1,391
|
|||||||||||||
|
Total
|
$
|
303,662
|
$
|
264,375
|
$
|
(291,662)
|
$
|
(123,569
|
)
|
$
|
153,154
|
|||||||||
|
1)
|
Persuasive
evidence of an arrangement exists.
|
|
2)
|
Fulfillment of the obligation has occurred or services have been rendered.
|
|
3)
|
The amount of the grant is fixed and determinable.
|
|
4)
|
Collectability is reasonably assured.
|
|
December 31,
|
||||||||
|
2015
|
2014
|
|||||||
|
U.S. Statutory rates
|
34
|
%
|
34
|
%
|
||||
|
Foreign income not recognized in the U.S.
|
(34%)
|
(34
|
%)
|
|||||
|
Dutch income tax rate
|
20
|
%
|
20
|
%
|
||||
|
Equity Method Pick-Up – Symbid Holding
|
(9.02)
|
(9.53
|
)
|
|||||
|
Other, less than 1%
|
(.10)
|
(.15
|
)
|
|||||
|
Effective income tax rate
|
10.88
|
10.32
|
||||||
|
Effect on valuation allowance
|
(10.88)
|
(10.32
|
)
|
|||||
|
Effective income tax rate
|
0
|
%
|
0
|
%
|
||||
|
For the years ended
December 31,
|
Shares of Restricted Common Stock
|
|||
|
2016
|
500,000 | |||
|
2017
|
250,000 | |||
| 750,000 | ||||
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|